Surmodics Inc 's (SRDX) Outlook

Company Name, Ticker, Suppliers, else..

Surmodics Inc (NASDAQ: SRDX)

Sector • Healthcare Industry • Medical Equipment & Supplies

Industry • Medical Equipment & Supplies

Sector • Healthcare

Surmodics Inc Outlook

On May 1 2024 the Surmodics Inc provided following guidance

Surmodics Inc., a renowned provider of cutting-edge medical device and in vitro diagnostic technologies, recently released their financial results for the second quarter of fiscal year 2024. The company reported a total revenue of $32.0 million, marking an impressive 18% increase compared to the previous year. This growth in revenue was attributed to various factors contributing to the company's success in the healthcare industry.

It is worth noting that the total revenue figure mentioned above excludes the revenue generated from Surmodics' SurVeil drug-coated balloon (DCB) product. This exclusion was done to provide a clearer picture of the company's overall financial performance, sans the potentially skewed impact of one particular product.

In light of these positive financial results, Surmodics Inc. also took the opportunity to update its financial guidance for the full fiscal year ending on September 30, 2024. This update reflects the company's confidence in its continued growth and financial stability moving forward.

Overall, Surmodics Inc.'s recent financial performance and updated guidance paint a promising picture for the company's future prospects, highlighting its strong position within the healthcare industry and its commitment to innovation and excellence in medical technology.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.